Key points are not available for this paper at this time.
miR-155 may be a therapeutic target in viral myocarditis; hypothesis-generating from Level 5 evidence and needs clinical validation.
Our data show that cardiac microRNA dysregulation is a characteristic of both human and mouse viral myocarditis. The inflammatory microRNA-155 is upregulated during acute myocarditis, contributes to the adverse inflammatory response to viral infection of the heart, and is a potential therapeutic target for viral myocarditis.
No takes yet. Share an insight, caveat, or question.
Corsten et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: